Showing results (321-330 of 331) with videos related to
Sort By:
Pageof 34
Molecular and Cellular Neurosciences|June 21, 2001
Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient miceH M Prosser, C H Gill, W D Hirst, et al.Molecular and Cellular Neurosciences|March 6, 2007
The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's diseaseDavid R Riddell, Hua Zhou, Thomas A Comery, et al.Proceedings of the National Academy of Sciences of the United States of America|January 14, 2021
The Parkinson's disease-associated gene ITPKB protects against α-synuclein aggregation by regulating ER-to-mitochondria calcium releaseDaniel J Apicco, Evgeny Shlevkov, Catherine L Nezich, et al.Scientific Reports|January 24, 2024
Dose-dependent reduction of somatic expansions but not Htt aggregates by di-valent siRNA-mediated silencing of MSH3 in HdhQ111 miceRachelle Driscoll, Lucas Hampton, Neeta A Abraham, et al.Biochemical Pharmacology|February 6, 2007
Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in ratsAndrew D Medhurst, Michael A Briggs, Gordon Bruton, et al.The Journal of Pharmacology and Experimental Therapeutics|January 10, 2008
Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)Warren D Hirst, Terrance H Andree, Suzan Aschmies, et al.Molecular Therapy. Advances|July 9, 2026
Intra-CNS AAV9-GBA1 delivery yields species and route of administration differences in safety and transgene expressionAna Claudia Amaral, Branka Grubor, Davide Gianni, et al.Chemical Reviews|June 30, 2020
Vibrational Spectroscopic Map, Vibrational Spectroscopy, and Intermolecular InteractionCarlos R Baiz, Bartosz Błasiak, Jens Bredenbeck, et al.Journal of Medicinal Chemistry|May 7, 2010
The synthesis and biological evaluation of quinolyl-piperazinyl piperidines as potent serotonin 5-HT1A antagonistsWayne E Childers, Lisa M Havran, Magda Asselin, et al.Nature Medicine|March 25, 2026
LRRK2-targeting antisense oligonucleotide in Parkinson's disease: a phase 1 randomized controlled trialOmar S Mabrouk, Ben Tichler, H Moore Arnold, et al.Pageof 34